Panacea Biotec Limited

NSE:PANACEABIO.NS

412.3 (INR) • At close July 30, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 1,325.31,634.91,473.51,157.21,364.61,5051,430.21,291.91,258.991,1521,051.21,1071,387.231,558.82,321.71,324.51,611.091,417.61,820.21,327.61,184.861,677.41,251.81,257.81,223.461,103.81,203.3992.8
Kosten van de omzet 520.8625.5431.9879.5969.91,140.8581.9548.6574.8477.8364.51,109.51,069.07465.91,038.8426.3588.81425.1638394.4395.55522.8368.9280.71,093.59253.4435.4244.7
Brutowinst 804.51,009.41,041.6277.7394.7364.2848.3743.3684.19674.2686.7-2.5318.161,092.91,282.9898.21,022.28992.51,182.2933.2789.311,154.6882.9977.1129.87850.4767.9748.1
Brutowinstmarge 0.6070.6170.7070.240.2890.2420.5930.5750.5430.5850.653-0.0020.2290.7010.5530.6780.6350.70.6490.7030.6660.6880.7050.7770.1060.770.6380.754
Onderzoek- en ontwikkelingskosten 00000000328.40000000390.170000000255.83000
Algemene en administratieve kosten 0000418.23000247.49000471.63000472.5000396.65000393.75000
Verkoop- en marketingkosten 0000113.04000218.21000220.05000183.74000209.78000136.44000
Verkoop-, algemene en administratieve kosten 58200504.9531.27456.8508.70465.7440.40-2.5691.68000656.24000606.431,154.600530.19000
Overige kosten 1,157.51,019.61,058.4000339.6743.30139.4686.7001,079.81,282.9898.20992.51,182.2933.2-108.430882.9977.1129.85850.4767.9748.1
Bedrijfskosten 1,157.51,019.61,058.4504.9543.2456.8848.3743.3886.57595.1686.7-2.5687.791,079.81,282.9898.2783.26992.51,182.2933.2611.521,154.6882.9977.1385.68850.4767.9748.1
Bedrijfsresultaat -353-10.2-16.8-227.2-148.5-92.6-128.7383.6-99.74354-137.3-323.3-369.6313.1-48.8-126.1-49.638.4266.3112.1210261.1-170.7120.2-255.81-263.9-234352.2
Bedrijfsresultaat ratio -0.266-0.006-0.011-0.196-0.109-0.062-0.090.297-0.0790.307-0.131-0.292-0.2660.008-0.021-0.095-0.0310.0270.1460.0840.1770.156-0.1360.096-0.209-0.239-0.1940.355
Totaal overige inkomsten en kosten netto 352.65464.456.7127.376.150.9-253.3281.89-129.6370.4-188.316,452.23-504.7-481.3-446.6-476.96-438.5-454.4-439.8-802.4-439.4-534-3572,128.46174.2-751.1-663.9
Inkomen voor belasting -0.443.847.6-170.5-21.2-16.5-77.8130.3182.15224.4233.1-511.616,082.6-491.6-530.1-572.7-526.56-400.1-188.1-327.7-592.4-178.3-704.7-236.81,872.65-89.7-985.1-311.7
Inkomen voor belasting ratio -00.0270.032-0.147-0.016-0.011-0.0540.1010.1450.1950.222-0.46211.593-0.315-0.228-0.432-0.327-0.282-0.103-0.247-0.5-0.106-0.563-0.1881.531-0.081-0.819-0.314
Belastingkosten 19.5-0.60.5-11.7-1.35.55.120.5308.930.776.149.83,707.850.400.814.870.40.93.491.523.123.528.325.9749-24.526.6
Nettowinst -18.945.248-158-16.63-22.8-82.9109.8-121.67193.7157-561.412,374.45-492-530.1-573.5-541.86-400.5-193.3-341.3-696.77-213.2-750-282.71,859.27-159.4-970-352.6
Nettowinstmarge -0.0140.0280.033-0.137-0.012-0.015-0.0580.085-0.0970.1680.149-0.5078.92-0.316-0.228-0.433-0.336-0.283-0.106-0.257-0.588-0.127-0.599-0.2251.52-0.144-0.806-0.355
WPA (Winst Per Aandeel) -0.310.740.77-2.59-0.23-0.37-1.351.79-2.073.162.56-9.17202.03-8.03-8.65-9.36-8.85-6.54-3.16-5.58-11.38-3.48-12.25-4.6230.39-2.6-15.83-5.75
Verwaterde WPA -0.310.740.77-2.59-0.23-0.37-1.351.79-2.073.162.56-9.17202.02-8.03-8.65-9.36-8.85-6.54-3.16-5.58-11.38-3.48-12.25-4.6230.39-2.6-15.83-5.75
EBITDA 94.2143.5144.2-74.575.183.124.4235.1287.7330.7343.8-398.616,500.7135.280.516.851.78170.4400.8237.3-48.9401.4-179.1284.8-663.8255.7-556.479.2
EBITDA ratio 0.0710.0880.098-0.0640.0550.0550.0170.1820.2290.2870.327-0.3611.8950.0870.0350.0130.0320.120.220.179-0.0410.239-0.1430.226-0.5430.232-0.4620.08